Pierre Beauparlant

Investor

About

Beauparlant, a Ph.D. with over 25 years in large pharma and venture-backed biopharma from discovery to commercialization, has served as CEO of Sanderling portfolio companies including PreciThera and SpecificiT Pharma.

Colleagues at Sanderling Ventures

Benjamin F. McGraw III

Venture Partner at Sanderling Ventures

Fred Middleton

Managing Director at Sanderling Ventures

Michael Dixon

Principal at Sanderling Ventures

Paulette Taylor

General Counsel & Principal at Sanderling Ventures

Peter McWilliams

Venture Partner at Sanderling Ventures

Robert G. McNeil

Founding Partner at Sanderling Ventures

Timothy Mills

Managing Director at Sanderling Ventures

Timothy Wollaeger

Managing Director Emeritus at Sanderling Ventures